Report Detail

Request for Sample of this report

Medical Devices & Consumables COVID-19 Impact on Global Nuclear Medicine Radioisotopes Market Insights, Forecast to 2026

  • RnM3990069
    • |
  • 05 June, 2020
    • |
  • Global
    • |
  • 111 Pages
    • |
  • QYResearch
    • |
  • Medical Devices & Consumables

Nuclear Medicine Radioisotopes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nuclear Medicine Radioisotopes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Nuclear Medicine Radioisotopes market is segmented into
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other

Segment by Application, the Nuclear Medicine Radioisotopes market is segmented into
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other

Regional and Country-level Analysis
The Nuclear Medicine Radioisotopes market is analysed and market size information is provided by regions (countries).
The key regions covered in the Nuclear Medicine Radioisotopes market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Nuclear Medicine Radioisotopes Market Share Analysis

Nuclear Medicine Radioisotopes market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Nuclear Medicine Radioisotopes by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Nuclear Medicine Radioisotopes business, the date to enter into the Nuclear Medicine Radioisotopes market, Nuclear Medicine Radioisotopes product introduction, recent developments, etc.
The major vendors covered:
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami


1 Study Coverage

  • 1.1 Nuclear Medicine Radioisotopes Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Type
    • 1.4.2 Thallium-201 (Tl-201)
    • 1.4.3 Iodine (I-123)
    • 1.4.4 Fluorine-18
    • 1.4.5 Rubidium-82 (Rb-82)
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Nuclear Medicine Radioisotopes Market Size Growth Rate by Application
    • 1.5.2 Tumor
    • 1.5.3 Heart Disease
    • 1.5.4 Lymphoma
    • 1.5.5 Thyroid Gland
    • 1.5.6 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Nuclear Medicine Radioisotopes Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Nuclear Medicine Radioisotopes Industry
      • 1.6.1.1 Nuclear Medicine Radioisotopes Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Nuclear Medicine Radioisotopes Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Nuclear Medicine Radioisotopes Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Nuclear Medicine Radioisotopes Market Size Estimates and Forecasts
    • 2.1.1 Global Nuclear Medicine Radioisotopes Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Nuclear Medicine Radioisotopes Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Nuclear Medicine Radioisotopes Production Estimates and Forecasts 2015-2026
  • 2.2 Global Nuclear Medicine Radioisotopes Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Nuclear Medicine Radioisotopes Manufacturers Geographical Distribution
  • 2.4 Key Trends for Nuclear Medicine Radioisotopes Markets & Products
  • 2.5 Primary Interviews with Key Nuclear Medicine Radioisotopes Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production Capacity
    • 3.1.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Nuclear Medicine Radioisotopes Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Nuclear Medicine Radioisotopes Manufacturers Market Share by Production
  • 3.2 Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue
    • 3.2.1 Global Top Nuclear Medicine Radioisotopes Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Nuclear Medicine Radioisotopes Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine Radioisotopes Revenue in 2019
  • 3.3 Global Nuclear Medicine Radioisotopes Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Nuclear Medicine Radioisotopes Production by Regions

  • 4.1 Global Nuclear Medicine Radioisotopes Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Nuclear Medicine Radioisotopes Regions by Production (2015-2020)
    • 4.1.2 Global Top Nuclear Medicine Radioisotopes Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Nuclear Medicine Radioisotopes Production (2015-2020)
    • 4.2.2 North America Nuclear Medicine Radioisotopes Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Nuclear Medicine Radioisotopes Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Nuclear Medicine Radioisotopes Production (2015-2020)
    • 4.3.2 Europe Nuclear Medicine Radioisotopes Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Nuclear Medicine Radioisotopes Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Nuclear Medicine Radioisotopes Production (2015-2020)
    • 4.4.2 China Nuclear Medicine Radioisotopes Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Nuclear Medicine Radioisotopes Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Nuclear Medicine Radioisotopes Production (2015-2020)
    • 4.5.2 Japan Nuclear Medicine Radioisotopes Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Nuclear Medicine Radioisotopes Import & Export (2015-2020)

5 Nuclear Medicine Radioisotopes Consumption by Region

  • 5.1 Global Top Nuclear Medicine Radioisotopes Regions by Consumption
    • 5.1.1 Global Top Nuclear Medicine Radioisotopes Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Nuclear Medicine Radioisotopes Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Nuclear Medicine Radioisotopes Consumption by Application
    • 5.2.2 North America Nuclear Medicine Radioisotopes Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Nuclear Medicine Radioisotopes Consumption by Application
    • 5.3.2 Europe Nuclear Medicine Radioisotopes Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Nuclear Medicine Radioisotopes Consumption by Application
    • 5.4.2 Asia Pacific Nuclear Medicine Radioisotopes Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Nuclear Medicine Radioisotopes Consumption by Application
    • 5.5.2 Central & South America Nuclear Medicine Radioisotopes Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Application
    • 5.6.2 Middle East and Africa Nuclear Medicine Radioisotopes Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Nuclear Medicine Radioisotopes Market Size by Type (2015-2020)
    • 6.1.1 Global Nuclear Medicine Radioisotopes Production by Type (2015-2020)
    • 6.1.2 Global Nuclear Medicine Radioisotopes Revenue by Type (2015-2020)
    • 6.1.3 Nuclear Medicine Radioisotopes Price by Type (2015-2020)
  • 6.2 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2021-2026)
    • 6.2.1 Global Nuclear Medicine Radioisotopes Production Forecast by Type (2021-2026)
    • 6.2.2 Global Nuclear Medicine Radioisotopes Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Nuclear Medicine Radioisotopes Price Forecast by Type (2021-2026)
  • 6.3 Global Nuclear Medicine Radioisotopes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Nuclear Medicine Radioisotopes Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Nuclear Medicine Radioisotopes Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Agfa-Gevaert Group
    • 8.1.1 Agfa-Gevaert Group Corporation Information
    • 8.1.2 Agfa-Gevaert Group Overview and Its Total Revenue
    • 8.1.3 Agfa-Gevaert Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Agfa-Gevaert Group Product Description
    • 8.1.5 Agfa-Gevaert Group Recent Development
  • 8.2 Braco
    • 8.2.1 Braco Corporation Information
    • 8.2.2 Braco Overview and Its Total Revenue
    • 8.2.3 Braco Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Braco Product Description
    • 8.2.5 Braco Recent Development
  • 8.3 Cardiarc
    • 8.3.1 Cardiarc Corporation Information
    • 8.3.2 Cardiarc Overview and Its Total Revenue
    • 8.3.3 Cardiarc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Cardiarc Product Description
    • 8.3.5 Cardiarc Recent Development
  • 8.4 Cardinal Health
    • 8.4.1 Cardinal Health Corporation Information
    • 8.4.2 Cardinal Health Overview and Its Total Revenue
    • 8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Cardinal Health Product Description
    • 8.4.5 Cardinal Health Recent Development
  • 8.5 CMR Naviscan (Gamma Medica Inc.)
    • 8.5.1 CMR Naviscan (Gamma Medica Inc.) Corporation Information
    • 8.5.2 CMR Naviscan (Gamma Medica Inc.) Overview and Its Total Revenue
    • 8.5.3 CMR Naviscan (Gamma Medica Inc.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 CMR Naviscan (Gamma Medica Inc.) Product Description
    • 8.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Development
  • 8.6 Curium
    • 8.6.1 Curium Corporation Information
    • 8.6.2 Curium Overview and Its Total Revenue
    • 8.6.3 Curium Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Curium Product Description
    • 8.6.5 Curium Recent Development
  • 8.7 Digirad
    • 8.7.1 Digirad Corporation Information
    • 8.7.2 Digirad Overview and Its Total Revenue
    • 8.7.3 Digirad Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Digirad Product Description
    • 8.7.5 Digirad Recent Development
  • 8.8 GE Healthcare
    • 8.8.1 GE Healthcare Corporation Information
    • 8.8.2 GE Healthcare Overview and Its Total Revenue
    • 8.8.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 GE Healthcare Product Description
    • 8.8.5 GE Healthcare Recent Development
  • 8.9 Nordion (Canada)
    • 8.9.1 Nordion (Canada) Corporation Information
    • 8.9.2 Nordion (Canada) Overview and Its Total Revenue
    • 8.9.3 Nordion (Canada) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Nordion (Canada) Product Description
    • 8.9.5 Nordion (Canada) Recent Development
  • 8.10 NTP Radioisotopes SOC
    • 8.10.1 NTP Radioisotopes SOC Corporation Information
    • 8.10.2 NTP Radioisotopes SOC Overview and Its Total Revenue
    • 8.10.3 NTP Radioisotopes SOC Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 NTP Radioisotopes SOC Product Description
    • 8.10.5 NTP Radioisotopes SOC Recent Development
  • 8.11 Positron
    • 8.11.1 Positron Corporation Information
    • 8.11.2 Positron Overview and Its Total Revenue
    • 8.11.3 Positron Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Positron Product Description
    • 8.11.5 Positron Recent Development
  • 8.12 Segami
    • 8.12.1 Segami Corporation Information
    • 8.12.2 Segami Overview and Its Total Revenue
    • 8.12.3 Segami Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Segami Product Description
    • 8.12.5 Segami Recent Development
  • 8.13 Siemens Healthcare
    • 8.13.1 Siemens Healthcare Corporation Information
    • 8.13.2 Siemens Healthcare Overview and Its Total Revenue
    • 8.13.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Siemens Healthcare Product Description
    • 8.13.5 Siemens Healthcare Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Nuclear Medicine Radioisotopes Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Nuclear Medicine Radioisotopes Regions Forecast by Production (2021-2026)
  • 9.3 Key Nuclear Medicine Radioisotopes Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Nuclear Medicine Radioisotopes Consumption Forecast by Region

  • 10.1 Global Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
  • 10.2 North America Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Nuclear Medicine Radioisotopes Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Nuclear Medicine Radioisotopes Sales Channels
    • 11.2.2 Nuclear Medicine Radioisotopes Distributors
  • 11.3 Nuclear Medicine Radioisotopes Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Nuclear Medicine Radioisotopes Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Nuclear Medicine Radioisotopes. Industry analysis & Market Report on COVID-19 Impact on Global Nuclear Medicine Radioisotopes is a syndicated market report, published as COVID-19 Impact on Global Nuclear Medicine Radioisotopes Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Nuclear Medicine Radioisotopes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,900.00
    		$7,350.00
    		$9,800.00
    		3,787.70
    		5,681.55
    		7,575.40
    		4,561.90
    		6,842.85
    		9,123.80
    		748,181.00
    		1,122,271.50
    		1,496,362.00
    		413,560.00
    		620,340.00
    		827,120.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo